@ErudioHealth profile picture
Erudio Health @ErudioHealth
Joined January 2023
  • Tweets 11
  • Following 4
  • Followers 28
2 Photos and videos
Pinned Tweet
Erudio Health
@ErudioHealth
27 Jan 2025
❤️
Medscape
@Medscape
24 Jan 2025
🚨 Exciting News for HOC 2025! 🚨 We are thrilled to unveil our brand-new, interactive #AI tool—“Agent HoC” at the Medscape Live Booth located in the Exhibit Hall! ✨Don’t miss out on this learning experience! #AgentHoc #CardiologyEducation #HeartofCardio #AItool
8
5
359
Erudio Health retweeted
ChatCME
@chatCME
Apr 27
In a noisy information market, good content is not enough. If trust stays invisible, the loudest voice can still win.
1
1
2
63
Erudio Health retweeted
ChatCME
@chatCME
Apr 21
"Interactive" is not a strategy. "Team-based" is not a mechanism. The proof bar is moving from format labels to a harder question: why should this design change practice?
1
1
1
52
Embed AI chat inside accredited CME activities, measure learning objectives, and share insights with commercial supporters.
ChatCME
@chatCME
24 Nov 2025
Guardrailed AI with cited answers for HCPs, outcomes analytics for CME providers, and knowledge‑gap insights for supporters.
0:31
1
97
Erudio Health retweeted
ChatCME
@chatCME
24 Nov 2025
Guardrailed AI with cited answers for HCPs, outcomes analytics for CME providers, and knowledge‑gap insights for supporters.
0:31
3
1
5
2,604
11
8
202
Erudio Health retweeted
Audun Utengen
@audvin
3 Dec 2024
We built the AI agent for @Medscape. Experience the acceleration of medical education at the @ASH_hematology Annual Meeting. This was made possible through our partnership with @MedscapeCME under the leadership of Dr. Sushant Dahiya, Natasha McGrath, MBA, and Laura Gaskell. @ErudioHealth will be in San Diego. Reach out to @tmlfox or me. #ASH24
1
3
4
654
Erudio Health retweeted
Kamran Mirza MD PhD - کامران مرزا
@KMirza
5 Jun 2023
#MedAffairsGPT is a game changer #ASCO23 cc: @ASCO ai.erudio.com
0:24
1
5
23
4,207
Erudio Health retweeted
The Innovation | Medicine
@Innov_Medicine
5 Jun 2023
Chat with the abstracts ai.erudio.com #ASCO23 @ErudioHealth

Audun Utengen
@audvin
5 Jun 2023
"What is the long-term safety of pirtobrutinib in patients with relapsed/refractory B-cell malignancies after at least 12 months of treatment?" Chat with the abstracts 👉 ai.erudio.com #ASCO23 @ErudioHealth
0:36
5
8
33,287
Erudio Health retweeted
Audun Utengen
@audvin
2 Jun 2023
Over 5,000 abstracts from #ASCO23 is a lot. What if you could simply chat with the abstracts? Start a conversation now 👉 ai.erudio.com From @ErudioHealth with @tmlfox.
1
6
9
1,569
A sneak peak at MedAffairsGPT. Chat with the abstracts 👉 ai.erudio.com #ASCO23 Edition
0:36
1
85
Load more